AR003436A1 - Ligandos de p-seletina y moleculas, acidos nucleicos purificados, vector, celula y uso de dichas moleculas para preparar medicamentos. - Google Patents

Ligandos de p-seletina y moleculas, acidos nucleicos purificados, vector, celula y uso de dichas moleculas para preparar medicamentos.

Info

Publication number
AR003436A1
AR003436A1 ARP960103147A AR10314796A AR003436A1 AR 003436 A1 AR003436 A1 AR 003436A1 AR P960103147 A ARP960103147 A AR P960103147A AR 10314796 A AR10314796 A AR 10314796A AR 003436 A1 AR003436 A1 AR 003436A1
Authority
AR
Argentina
Prior art keywords
molecules
ligands
nucleic acids
purified nucleic
seletine
Prior art date
Application number
ARP960103147A
Other languages
English (en)
Spanish (es)
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of AR003436A1 publication Critical patent/AR003436A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/473—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used alpha-Glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
ARP960103147A 1995-06-14 1996-06-13 Ligandos de p-seletina y moleculas, acidos nucleicos purificados, vector, celula y uso de dichas moleculas para preparar medicamentos. AR003436A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21395P 1995-06-14 1995-06-14

Publications (1)

Publication Number Publication Date
AR003436A1 true AR003436A1 (es) 1998-08-05

Family

ID=21690430

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960103147A AR003436A1 (es) 1995-06-14 1996-06-13 Ligandos de p-seletina y moleculas, acidos nucleicos purificados, vector, celula y uso de dichas moleculas para preparar medicamentos.

Country Status (14)

Country Link
EP (1) EP0833650A4 (cs)
JP (1) JPH11508131A (cs)
KR (1) KR19990022954A (cs)
AR (1) AR003436A1 (cs)
AU (1) AU6272996A (cs)
BR (1) BR9608918A (cs)
CA (1) CA2224625A1 (cs)
CZ (1) CZ401497A3 (cs)
HU (1) HUP9901131A2 (cs)
IL (1) IL122590A0 (cs)
NO (1) NO975862L (cs)
TR (1) TR199701620T1 (cs)
WO (1) WO1997000079A1 (cs)
ZA (1) ZA965032B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043834A2 (en) * 1998-02-27 1999-09-02 Genetics Institute, Inc. P-selectin ligand protein, including tetrameric fusion proteins
MXPA03005945A (es) * 2000-12-29 2004-10-15 Savient Pharmaceuticals Inc Moleculas aisladas que comprenden epitopes que contienen grupos sulfato, anticuerpos para tales epitopes y usos de ellos.
JP4599027B2 (ja) * 2002-10-30 2010-12-15 東洋水産株式会社 Ｌ−セレクチン結合阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0544815A1 (en) * 1990-07-17 1993-06-09 The Board Of Regents Of The University Of Oklahoma Peptides from the GMP-140 lectinbindingdomain and selectin binding ligands on carbonhydrates
US5318890A (en) * 1991-05-06 1994-06-07 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
AU681369B2 (en) * 1992-11-16 1997-08-28 Board Of Regents Of The University Of Oklahoma, The Glycoprotein ligand for P-selectin and methods of use thereof
WO1995030001A2 (en) * 1994-04-28 1995-11-09 Genetics Institute, Inc. Novel p-selectin ligand protein

Also Published As

Publication number Publication date
CZ401497A3 (cs) 1998-07-15
IL122590A0 (en) 1998-06-15
ZA965032B (en) 1997-03-14
NO975862L (no) 1998-02-12
CA2224625A1 (en) 1997-01-03
AU6272996A (en) 1997-01-15
KR19990022954A (ko) 1999-03-25
TR199701620T1 (xx) 1998-05-21
EP0833650A1 (en) 1998-04-08
JPH11508131A (ja) 1999-07-21
NO975862D0 (no) 1997-12-12
BR9608918A (pt) 1999-06-15
EP0833650A4 (en) 2005-01-19
WO1997000079A1 (en) 1997-01-03
HUP9901131A2 (hu) 1999-07-28

Similar Documents

Publication Publication Date Title
Deisenhofer et al. X-ray structure analysis of a membrane protein complex: electron density map at 3 Å resolution and a model of the chromophores of the photosynthetic reaction center from Rhodopseudomonas viridis
Feinstein et al. Conformation of the free and antigen-bound IgM antibody molecules
Bedarkar et al. Relaxin has conformational homology with insulin
BR9406716A (pt) Molécula de DNA isolada célula hospedeira vetor método para produzir uma proteina (BMP-10) polipeptideo de proteina-10 morfogenética de osso purificada (BMP-10) e molécula de DNA quimérica
ES2127831T3 (es) Unidades de expresion multicistronicas y su aplicacion.
DK0720482T3 (da) Prosaposin og cytokin-afledte peptider som terapeutiske midler
KR880701288A (ko) M-csf의 제법
DE69304065T2 (de) Herstellung und verwendung von, auf basis von cyclodextrin dispergierbaren kolloidal-systemen, in form von nanokugeln
ATE204298T1 (de) Hybrider mensch/tier faktor viii
ES2147553T3 (es) Vectores virales recombinantes para la expresion en unas celulas musculares.
NO178653C (no) Fremgangsmåte for fremstilling av liposomer og/eller biologiske celler, i hvilke er inkludert tilsetningstoffer
PT733103E (pt) Criacao de elevados titulos de vectores de aav recombinantes
ATE270337T1 (de) Materialen und methoden im zusammenhang mit bindung und präsentation von substanzen auf zelloberflächen
ATE142691T1 (de) Proteine mit faktor-viii-aktivität, verfahren zu deren herstellung unter verwendung von genetisch modifizierten zellen und diese enthaltende pharmazeutische zusammensetzungen
ATE110782T1 (de) Rekombinanter menschlicher endothelzellenwachstumsfaktor.
PT100245A (pt) Sequencia de adn que codifica um derivado de factor viii humano recombinante, biologicamente activo, vector de expressao recombinante, celula hospedeira, processo de producao de um derivado de factor vii e derivado de factor viii
DE69420034T2 (de) Synthetische mischpeptide, die die entstehung von neutralisierenden antikörpern und die wirkung der cytotoxischen t-lymphozyten gegen hiv hervorufen
AR003427A1 (es) Péptidos relacionados con dolastatina, procedimiento para prepararlos, composiciones farmacéuticas que los contienen y el uso de los mismos para la preparación de dichas composiciones farmacéuticas.
HUP9702377A2 (hu) Önfelerősítő, gyógyszeres úton szabályozható expressziós rendszerek
KR930010177A (ko) 하이브리드 형질전환 성장인자
HUP9900751A2 (hu) Parathormontartalmú stabil gyógyászati készítmény
AR003436A1 (es) Ligandos de p-seletina y moleculas, acidos nucleicos purificados, vector, celula y uso de dichas moleculas para preparar medicamentos.
Yamasaki et al. 3ircular dichroism simulation shows a site-II-to-site-I displacement of human serum albumin-bound diclofenac by ibuprofen
DE69102651D1 (de) Proteaseresistenter pdgf und dessen verwendungen.
Dounce Nuclear Gels and Chromosomal Structure: A study of viscoelastic gel formation by isolated cell nuclei is brought to bear on the problem of how mammalian chromosomes are put together